Cho‐Chin Cheng

Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern

Paul R. Wratil, Marcel Stern, Alina Priller et al. · Nature Medicine · 2022 · 284 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents

Nina Koerber, Alina Priller, Sarah Yazici et al. · Nature Communications · 2022 · 86 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread

Shubhankar Ambike, Cho‐Chin Cheng, Martin Feuerherd et al. · Nucleic Acids Research · 2021 · 69 citations · Full text

Life Sciences, Biology, Infectious Diseases +16

Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes

Domizia Baldassi, Shubhankar Ambike, Martin Feuerherd et al. · Journal of Controlled Release · 2022 · 44 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +14

Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing

Max Luedemann, Daniela Stadler, Cho‐Chin Cheng et al. · Computational and Structural Biotechnology Journal · 2022 · 32 citations · Full text

Pharmacy, Immunology, Pharmacology +17